Le Lézard
Classified in: Health, Science and technology
Subject: Product/Service

Scientist.com Unveils Elisa: An LLM-Powered Research Assistant for Scientists in the Pharmaceutical and Biotechnology Industries

Scientist.com, the world's leading marketplace for biopharma research, today announced the launch of a new large language model (LLM)-powered research assistant called Elisa, named in homage to a widely used research assay and to ELIZA, an early 1960s chatbot. Elisa is the newest addition to a suite of proprietary AI-powered apps created by Scientist.com to improve and accelerate drug research. Marketplace users can now benefit from a powerful, scalable, and intuitive LLM assistant that understands the nuances of pharmaceutical research and has been trained on Scientist.com's public data sources.

"Elisa is a bridge between advanced technology and our customers, providing them with instant access to marketplace information and a conversational interface that understands their research needs," said Chris Petersen, Founder and CTO of Scientist.com. "It's the latest in a series of LLM-powered tools we've built to help life science researchers run their drug discovery programs faster and at lower cost."

Elisa addresses three key challenges for pharma and biotech companies integrating large language models into their operations:

1. It guarantees complete privacy and confidentiality of all data.

2. It provides a cost-efficient solution with the capabilities and flexibility of high-end platforms like Azure or Amazon.

3. It eliminates the need for extensive technical expertise to develop and operate a private LLM on your own infrastructure.

Other LLM-enabled tools on the Scientist.com marketplace help marketplace users negotiate pricing with suppliers, respond quickly to supplier messages, find services and products, and understand legal agreements.

The company also uses machine learning algorithms trained on nearly a decade of marketplace data to create proprietary predictive models that help researchers find and evaluate the best technology and labs for their research needs as well as forecast supplier performance once the research project is initiated. These include the Tumor Model FinderTM, which compares DNA sequencing data on 10,000 oncology models to help researchers identify and purchase the most appropriate model.

To learn more about how Scientist.com is using artificial intelligence across its platform, visit https://scientist.com/ai/ or contact [email protected].

About Scientist.com

Scientist.com is the world's leading AI-enabled marketplace for scientific research. The marketplace simplifies drug discovery research, saving time and money and providing access to the latest innovative tools and technologies. Scientist.com operates private enterprise marketplaces for most of the world's major pharmaceutical companies, over 100 biotechnology companies, and the US NIH.

Media contact: For additional information or to schedule an interview with Chris Petersen, please contact Sean at [email protected].

These press releases may also interest you

at 15:01
Marpai, Inc. ("Marpai" or the "Company") , an independent national Third-Party Administration company transforming the $22 billion TPA market supporting self-funded employer health plans with affordable, intelligent, healthcare, today announced that...

at 14:59
In a commitment to furthering its partnership with Cooper University Health Care and bolstering essential services for the Camden community, Subaru of America, Inc., has announced its continued support of $30,000 for durable medical equipment and...

at 14:48
Children's Aid and Family Services, a Paramus-based nonprofit human services agency, recently introduced the availability of convenient, no-cost, in-home therapy for pre-and post-adoptive and kinship families....

at 14:18
The 2024 Veterinary Innovation Summit (VIS), presented by the North American Veterinary Community (NAVC) and the Veterinary Innovation Council (VIC), will focus on Artificial Intelligence (AI) applications within veterinary medicine, the evolution of...

at 14:15
Avvio Medical, Inc. (formerly Applaud Medical), a company dedicated to revolutionizing the treatment of urinary stones, today announced a bold step forward with a new name that reflects the Company's vision for the future. "Avvio is more than just...

at 14:15
Senderra Specialty Pharmacy announced today the launch of SenderraCare+. This innovative digital solution provides patients with a seamless, interactive patient journey in real-time, including status updates regarding their medication and two-way...

News published on and distributed by: